TFAP2A and neoplasm: The subcutaneous tumours were analysed by IHC, which demonstrated that the expression levels of TFAP2A, ESR2 and Ki67 were decreased in tumours derived from TFAP2A-knockdown cells but increased in tumours derived from TFAP2A-overexpressing cells (Fig. 4I, J).